B2i Digital, Inc. is highlighting the Life Sciences Virtual Investor Forum taking place March 11 and 12, 2026. The forum connects presenting companies with a global audience of individual and institutional investors through live, interactive online presentations. This event represents a significant opportunity for life sciences companies to access capital and for investors to discover emerging opportunities in therapeutic and healthcare markets.
Participating companies deliver scheduled presentations followed by real-time Q&A sessions. Investors can request one-on-one meetings with management teams through the VIC platform, creating direct engagement opportunities that traditional investment forums often lack. After the event, presentation replays are made available for on-demand viewing, extending visibility and engagement beyond the live sessions. This extended access is particularly valuable for global investors operating across different time zones.
The forum features presentations from public life sciences companies across a broad range of therapeutic and healthcare markets. Presenting companies include SeaStar Medical Holding Corporation, Nasus Pharma Ltd., Tonix Pharmaceuticals Holding Corp., Jupiter Neurosciences, Inc., Bora Pharmaceuticals, Prostatype Genomics AB, MetaVia Inc., Phio Pharmaceuticals Corp., Avicanna Inc., EMVision Medical Devices Ltd., Aethlon Medical, Dyadic International, Jaguar Health, Inc., Beyond Air, Inc., Cadrenal Therapeutics, Inc., and Amplia Therapeutics Ltd. Among these are B2i Digital Featured Companies Jupiter Neurosciences, Inc. and Phio Pharmaceuticals Corp.
B2i Digital partners with Virtual Investor Conferences as Official Marketing Partner, supporting awareness for each event through digital marketing, social media promotion, digital profiles of presenting companies, and broader investor outreach. The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research. Virtual Investor Conferences is an OTC Markets Group Inc. property, with public companies listed on NYSE, Nasdaq, TSX, CSE, ASX, and OTC Markets participating in VIC events.
For business and technology leaders, this forum demonstrates the evolving landscape of investor engagement in the life sciences sector. The virtual format removes geographical barriers, allowing companies to reach a global investor base more efficiently than traditional in-person conferences. This accessibility is particularly important for smaller life sciences companies that may have limited resources for extensive investor roadshows. The platform's structure enables meaningful dialogue between management teams and potential investors, potentially accelerating funding for innovative therapies and medical technologies.
The implications for the industry are substantial as virtual investor conferences continue to gain prominence. These platforms democratize access to investment opportunities while providing companies with cost-effective ways to maintain visibility in competitive capital markets. For investors, the format offers unprecedented access to management teams and detailed company information that can inform investment decisions across the life sciences spectrum. The availability of presentation replays ensures that investment research can continue long after the live event concludes, supporting more thorough due diligence processes.
For comprehensive profiles of participating companies and registration, please visit https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/147666/march-12th-life-sciences-virtual-investor-forum?utm_source=b2i&utm_medium=marketing&utm_campaign=0326LifeSciencesVIC. Additional details about the event are available at https://b2idigital.com/otc-life-sciences-virtual-investor-forum.
